Skip to content
Biodatica
Start free

Iovance Biotherapeutics, Inc.

Phoenix, Arizona

Oncologycell therapyPhase IIListed · IOVA

This company trades under its own ticker, so it sits outside Biodatica’s pre-ticker window. The record stays here because its filings are real, but the feed leaves listed companies out unless you ask for them.

Compare Sign in to watch

What changed

Phase II trial registered: Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

2mo agoTrial registeredMay 15, 2026Source filing (opens the source filing in a new tab)

Momentum

64no change

Momentum 64 out of 100, unchanged since the last recompute.

Some recent activity, at a steady rate.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    PHASE2 registered

    May 7, 2019

    Metastatic Melanoma, Squamous Cell Carcinoma of the Head and Neck, Non-small Cell Lung Cancer · TERMINATED · sponsor: Iovance Biotherapeutics, Inc. · Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

    ClinicalTrials.gov · NCT03645928 (opens the source filing in a new tab)

  2. Trial

    PHASE2 registered

    Jun 22, 2017

    Cervical Carcinoma · TERMINATED · sponsor: Iovance Biotherapeutics, Inc. · Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma

    ClinicalTrials.gov · NCT03108495 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources